BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24853684)

  • 1. Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics.
    Trochine A; Creek DJ; Faral-Tello P; Barrett MP; Robello C
    PLoS Negl Trop Dis; 2014 May; 8(5):e2844. PubMed ID: 24853684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi chemical proteomics using immobilized benznidazole.
    Trochine A; Alvarez G; Corre S; Faral-Tello P; Durán R; Batthyany CI; Cerecetto H; González M; Robello C
    Exp Parasitol; 2014 May; 140():33-8. PubMed ID: 24632192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation.
    Hall BS; Wilkinson SR
    Antimicrob Agents Chemother; 2012 Jan; 56(1):115-23. PubMed ID: 22037852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoencapsulation of benznidazole in calcium carbonate increases its selectivity to Trypanosoma cruzi.
    Tessarolo LD; de Menezes RRPPB; Mello CP; Lima DB; Magalhães EP; Bezerra EM; Sales FAM; Barroso Neto IL; Oliveira MF; Dos Santos RP; Albuquerque EL; Freire VN; Martins AM
    Parasitology; 2018 Aug; 145(9):1191-1198. PubMed ID: 29642963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi
    Pandey RP; Nascimento MS; Franco CH; Bortoluci K; Silva MN; Zingales B; Gibaldi D; Castaño Barrios L; Lannes-Vieira J; Cariste LM; Vasconcelos JR; Moraes CB; Freitas-Junior LH; Kalil J; Alcântara L; Cunha-Neto E
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0028422. PubMed ID: 36314800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-
    Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol.
    Cafferata ML; Toscani MA; Althabe F; Belizán JM; Bergel E; Berrueta M; Capparelli EV; Ciganda Á; Danesi E; Dumonteil E; Gibbons L; Gulayin PE; Herrera C; Momper JD; Rossi S; Shaffer JG; Schijman AG; Sosa-Estani S; Stella CB; Klein K; Buekens P
    Reprod Health; 2020 Aug; 17(1):128. PubMed ID: 32831069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
    Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
    Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas disease.
    Hennig K; Abi-Ghanem J; Bunescu A; Meniche X; Biliaut E; Ouattara AD; Lewis MD; Kelly JM; Braillard S; Courtemanche G; Chatelain E; Béquet F
    Metabolomics; 2019 Aug; 15(9):117. PubMed ID: 31440849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis.
    Ciapponi A; Barreira F; Perelli L; Bardach A; Gascón J; Molina I; Morillo C; Prado N; Riarte A; Torrico F; Ribeiro I; Villar JC; Sosa-Estani S
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008529. PubMed ID: 32804966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione and trypanothione in several strains of Trypanosoma cruzi: effect of drugs.
    Repetto Y; Opazo E; Maya JD; Agosin M; Morello A
    Comp Biochem Physiol B Biochem Mol Biol; 1996 Oct; 115(2):281-5. PubMed ID: 8939007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole.
    Campos MC; Phelan J; Francisco AF; Taylor MC; Lewis MD; Pain A; Clark TG; Kelly JM
    Sci Rep; 2017 Oct; 7(1):14407. PubMed ID: 29089615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection.
    Strauss M; Lo Presti MS; Bazán PC; Baez A; Fauro R; Esteves B; Sanchez Negrete O; Cremonezzi D; Paglini-Oliva PA; Rivarola HW
    Parasitol Int; 2013 Jun; 62(3):293-9. PubMed ID: 23500720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
    Maya JD; Rodríguez A; Pino L; Pabón A; Ferreira J; Pavani M; Repetto Y; Morello A
    Biol Res; 2004; 37(1):61-9. PubMed ID: 15174306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candimine from Hippeastrum escoipense (Amaryllidaceae): Anti-Trypanosoma cruzi activity and synergistic effect with benznidazole.
    Ortiz JE; Piñeiro M; Martinez-Peinado N; Barrera P; Sosa M; Bastida J; Alonso-Padilla J; Feresin GE
    Phytomedicine; 2023 Jun; 114():154788. PubMed ID: 37037085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver and copper-benznidazole derivatives as potential antiparasitic metallodrugs: Synthesis, characterization, and biological evaluation.
    de Souza CC; de Azevedo-França JA; Barrias E; Cavalcante SCF; Vieira EG; Ferreira AMDC; de Souza W; Navarro M
    J Inorg Biochem; 2023 Feb; 239():112047. PubMed ID: 36428157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
    Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
    PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug transporter and oxidative stress gene expression in human macrophages infected with benznidazole-sensitive and naturally benznidazole-resistant Trypanosoma cruzi parasites treated with benznidazole.
    Téllez J; Romero I; Romanha AJ; Steindel M
    Parasit Vectors; 2019 May; 12(1):262. PubMed ID: 31126349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
    González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
    Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.